Abiologics
26 employees on LinkedIn · 1 known investors
Find your way into Abiologics
134 people in our graph share verified history with the Abiologics team — schools, employers, funds. One of them is your warm intro.
Anika Guptaunlockedknows Avak Kahvejian · together at Flagship Pioneering (overlapped)
knows the team · via Rubius Therapeutics
×8knows the team · via Flagship Pioneering
knows the team · via Cellarity
knows the team · via Codiakbio
Abiologics uses computational design tools to create protein-inspired molecules called Synteins, engineered to avoid the vulnerabilities of natural protein medicines while retaining biological function. The company develops these molecules as a new class of therapeutics with the aim of advancing candidates toward clinical development.
Founders & leadership
AK
Avak Kahvejianin𝕏Chairman (Founder / founding CEO)Avak Kahvejian was involved in conceiving and launching platform companies at Flagship Pioneering that leveraged new biological mechanisms and biotechnologies before founding Abiologics.
M
MikeChief Innovation Officer & Co-Founder
JD
Jaclyn DunphyinCo-Founder & Senior Director of Strategy and Research Operations
MM
Maria-Chiara MagnoneinChief Scientific Officer
Investors · 1
In the news
Frequently asked questions
- What does Abiologics do?
- Abiologics uses computational design tools to create protein-inspired molecules called Synteins, engineered to avoid the vulnerabilities of natural protein medicines while retaining biological function. The company develops these molecules as a new class of therapeutics with the aim of advancing candidates toward clinical development.
- Who founded Abiologics?
- Abiologics was founded by Avak Kahvejian, Mike, Jaclyn Dunphy.
- Who are Abiologics's investors?
- Abiologics's investors include Flagship Pioneering.